The inhibition of CAMKK2 protects against prostate cancer, hepatocellular carcinoma (HCC) and metabolic disorders induced by a high-fat diet (Lin and Wu, 2015). This evidence concerns the gene CAMKK2 and hepatocellular carcinoma.